Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Albemarle Reports Third Quarter 2025 Results

      Albemarle Corp. Logo. (PRNewsFoto/Albemarle Corporation)

      News provided by

      Albemarle Corporation

      Nov 05, 2025, 16:15 ET

      Share this article

      Share this article


      CHARLOTTE, N.C., Nov. 5, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the third quarter ended September 30, 2025.

      Third Quarter  2025 and Recent Highlights
      (Unless otherwise stated, all percentage changes represent year-over-year comparisons)

      • Net sales of $1.3 billion, including volume growth in Energy Storage (+8%) and Ketjen (+8%).
      • Net loss of ($161) million, or ($1.72) per diluted share attributable to common shareholders; Adjusted loss of ($0.19) per diluted share attributable to common shareholders excludes a non-cash goodwill impairment charge associated with Ketjen.
      • Adjusted EBITDA of $226 million; up 7% due to improved fixed cost absorption and on-going cost savings.
      • On track to achieve full-year run-rate cost and productivity improvements of approximately $450 million, surpassing initial $300 to $400 million target.
      • Third quarter cash from operations of $356 million was up 57%, or $128 million; year-to-date cash from operations of $894 million was also up 29%, or $202 million, due to cost and productivity improvements, cash management actions and a customer prepayment received in January.
      • Reducing full-year 2025 capital expenditures outlook to approximately $600 million.
      • Expect to achieve positive free cash flow(a) of $300 to $400 million for the full year 2025.
      • Enhancing full-year outlook considerations; enterprise results are expected to be towards the higher end of the previously published $9/kg scenario ranges given year-to-date financial performance and lithium market pricing and better-than-expected Energy Storage volumes.
      • On October 27, announced agreements to sell stakes in Ketjen and the Eurecat joint venture for combined pre-tax proceeds of approximately $660 million.

      "Our team delivered strong third quarter results, with adjusted EBITDA up year-over-year despite lower lithium prices, demonstrating the strength of our business and disciplined execution," said Kent Masters, Chairman and CEO. "Our successful implementation of cost and productivity improvements and reduced capital expenditures coupled with our recent portfolio management actions underscore our commitment to long-term value and enhanced financial flexibility. We remain confident in our full-year outlook and ability to navigate dynamic markets."

      Third Quarter 2025 Results

      In millions, except per share amounts

      Q3 2025


      Q3 2024


      $ Change


      % Change

      Net sales

      $    1,307.8


      $    1,354.7


      $        (46.9)


      (3.5) %

      Net loss attributable to Albemarle Corporation

      $      (160.7)


      $   (1,069.0)


      $       908.3


      85.0 %

      Adjusted EBITDA(b)

      $       225.6


      $       211.5


      $         14.1


      6.7 %

      Diluted loss per share attributable to common shareholders

      $        (1.72)


      $        (9.45)


      $         7.73


      81.8 %

         Non-recurring and other unusual items(b)

      1.53


      7.90





      Adjusted diluted loss per share attributable to common shareholders(b)(c)

      $        (0.19)


      $        (1.55)


      $         1.36


      87.7 %



      (a)

      A non-GAAP measure defined as operating cash flow minus capital expenditures. The company does not provide a reconciliation of forward-looking non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP, as the company is unable to estimate non-recurring or unusual items or their probable significance without unreasonable effort. See "Additional Information Regarding Non-GAAP Measures" for more information.

      (b)

      See Non-GAAP Reconciliations for further details.

      (c)

      Totals may not add due to rounding.

      Net sales for the third quarter of 2025 were $1.3 billion compared to $1.4 billion for the prior-year quarter, a decline of 3% driven primarily by lower pricing in Energy Storage, offset by higher volumes in Energy Storage and Ketjen. Adjusted EBITDA of $226 million increased by $14 million from the prior-year quarter as lower input costs and on-going cost reduction efforts offset reduced lithium pricing. Net loss attributable to Albemarle of ($161) million decreased year-over-year by $908 million, due primarily to restructuring charges recorded in the prior-year period. 

      The effective income tax rate for the third quarter of 2025 was 12.8% compared to (9.4)% in the same period of 2024. On an adjusted basis, the effective income tax rates were 50.9% and (12.9)% for the third quarters of 2025 and 2024, respectively, with the change primarily due to geographic income mix and the impact of tax valuation allowances in Australia and China.

      Energy Storage Results

      In millions

      Q3 2025


      Q3 2024


      $ Change


      % Change

      Net Sales

      $           708.8


      $           767.3


      $           (58.5)


      (7.6) %

      Adjusted EBITDA

      $           124.1


      $           142.9


      $           (18.8)


      (13.2) %

      Energy Storage net sales for the third quarter of 2025 were $709 million, a decrease of $59 million, or 8%, due to lower pricing (-16%). Volumes were up 8% due to higher spodumene sales, record production from our integrated conversion facilities and inventory reductions. Adjusted EBITDA of $124 million decreased $19 million, as lower input costs and on-going cost reduction efforts mostly offset lower lithium pricing.

      Specialties Results

      In millions

      Q3 2025


      Q3 2024


      $ Change


      % Change

      Net Sales

      $           345.0


      $           342.4


      $               2.6


      0.8 %

      Adjusted EBITDA

      $             75.5


      $             56.3


      $             19.3


      34.2 %

      Specialties net sales for the third quarter of 2025 were $345 million, an increase of $3 million, or 1%, as foreign exchange benefits offset slightly lower volumes (-1%) due to strength in demand for flame retardants in electrical and electronics applications offset by weakness in automotive end-markets. Adjusted EBITDA of $76 million increased $19 million versus the prior-year quarter due to decreased manufacturing costs related to productivity initiatives. 

      Ketjen Results

      In millions

      Q3 2025


      Q3 2024


      $ Change


      % Change

      Net Sales

      $           254.1


      $           245.0


      $               9.1


      3.7 %

      Adjusted EBITDA

      $             33.6


      $             35.5


      $              (1.9)


      (5.4) %

      Ketjen net sales for the third quarter of 2025 were $254 million, up 4% compared to the prior-year quarter as higher volumes (+8%) were partially offset by lower prices (-5%). Adjusted EBITDA of $34 million decreased $2 million, driven by lower prices and higher input costs partially offset by higher volumes and favorable clean fuels technology joint venture equity earnings. 

      2025 Outlook Considerations

      Total Corporate Outlook Considerations
      Albemarle is enhancing its prior full-year outlook considerations for the enterprise and Energy Storage, which are based on observed lithium market price scenarios. Full-year 2025 results are expected to be towards the higher end of the previously published $9/kg scenario ranges given year-to-date financial performance and lithium market pricing and better-than-expected Energy Storage volumes. Ketjen and Specialties outlook considerations are unchanged.

      The table below reflects expected outcomes for the total company based on recently observed lithium market price scenarios, and are unchanged from the prior quarter. Ranges are based on variation in sales volume and mix, including a projected increase in Energy Storage sales volumes of 0% to 10% in 2025 compared to 2024. All three scenarios assume flat market pricing flowing through Energy Storage's current contract book. Scenarios also assume spodumene pricing averages 10% of the lithium carbonate equivalent (LCE) price, while other costs are assumed to be constant.


      Total Corporate FY 2025E

      Including Energy Storage Scenarios

      Observed market price case(a)

      H1 2025 average

      H1 2024 range

      Q4 2023 average

      Average lithium market price ($/kg LCE)(a)

      ~$9

      $12-15

      ~$20

      Net sales

      $4.9 - $5.2 billion

      $5.3 - $6.1 billion

      $6.5 - $7.0 billion

      Adjusted EBITDA(b)

      $0.8 - $1.0 billion

      $1.2 - $1.8 billion

      $2.5 - $2.7 billion



      (a)

      Price represents blend of relevant market pricing including spot and regional indices for the periods referenced.

      (b)

      The company does not provide a reconciliation of forward-looking non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP, as the company is unable to estimate significant non-recurring or unusual items without unreasonable effort. See "Additional Information Regarding Non-GAAP Measures" for more information.

      Energy Storage Market Price Scenarios


      Energy Storage FY 2025E

      Observed market price case(a)

      H1 2025 average

      H1 2024 range

      Q4 2023 average

      Average lithium market price ($/kg LCE)(a)

      ~$9

      $12-15

      ~$20

      Net sales

      $2.5 - $2.6 billion

      $2.9 - $3.5 billion

      $4.2 - $4.5 billion

      Adjusted EBITDA

      $0.6 - $0.7 billion

      $1.0 - $1.5 billion

      $2.2 - $2.4 billion

      Equity in net income of unconsolidated investments (net of tax)(b)

      $0.2 - $0.3 billion

      $0.3 - $0.5 billion

      $0.6 - $0.7 billion



      (a)

      Price represents blend of relevant market pricing including spot and regional indices for the periods referenced.

      (b)

      Included in adjusted EBITDA on a pre-tax basis.

      Specialties and Ketjen Outlook Considerations
      Specialties outlook reflects volume growth in key end markets led by pharma, automotive and oilfield, partially offset by weakness in building and construction.

      Ketjen outlook assumes strong fluidized catalytic cracking (FCC) volume offset by lower clean fuel technologies (CFT) volume due to order timing.


      Segment FY 2025E

      Specialties net sales

      $1.3 - $1.5 billion

      Specialties adjusted EBITDA

      $210 - $280 million

      Ketjen net sales

      $1.0 - $1.1 billion

      Ketjen adjusted EBITDA

      $120 - $150 million

      Other Corporate Outlook Considerations
      Albemarle expects its 2025 capital expenditures to be approximately $600 million, down 65% from $1.7 billion in 2024. This level of spending reflects in part a timing impact and a continued prioritization on sustaining existing assets and resources. Reduced corporate costs reflect cost savings and foreign exchange gains to date.


      Other Corporate FY 2025E

      Capital expenditures

      ~$600 million

      Depreciation and amortization

      $630 - $670 million

      Adjusted effective tax rate(a)

      (40)% - 25%

      Corporate costs(b)

      $10 - $30 million

      Interest and financing expenses

      $180 - $210 million

      Weighted-average common shares outstanding (diluted)

      118 million



      (a)

      Adjusted effective tax rate dependent on lithium market prices and geographic income mix

      (b)

      FY 2025E outlook includes FX impact in the first nine months of 2025

      Cash Flow and Capital Deployment
      Cash from operations of $894 million in the first nine months of 2025 increased $202 million compared to the prior-year period due to cost and productivity improvements, cash management actions and a customer prepayment received in January. We now expect to achieve positive free cash flow of approximately $300 to $400 million for the full year 2025 given year-to-date financial performance and lithium market pricing and better-than-expected Energy Storage volumes. Capital expenditures of $434 million in the first nine months of 2025 decreased by $903 million versus the prior-year period, reflecting the impact of decisions that stopped or slowed spending and the completion of capacity expansions in Energy Storage and Specialties. We are reducing our full-year 2025 capital expenditures outlook to approximately $600 million.

      Balance Sheet and Liquidity
      As of September 30, 2025, Albemarle had estimated liquidity of approximately $3.5 billion, including $1.9 billion of cash and cash equivalents, $1.5 billion available under our revolver and $107 million available under other credit lines. Total debt was $3.6 billion, representing a net debt to adjusted EBITDA ratio (as defined in our credit agreement) of approximately 2.1 times. In the fourth quarter of 2025 our 1.125% Euro notes due November 2025 will mature, and we intend to repay those notes with cash on hand.

      Earnings Call

      Date:

      Thurs., November 6, 2025

      Time:

      8:00 AM Eastern time

      Dial-in (U.S.):

      1-800-590-8290

      Dial-in (International):

      1-240-690-8800

      Conference ID:

      ALBQ3

      The company's earnings presentation and supporting material are available on Albemarle's website at https://investors.albemarle.com.

      About Albemarle
      Albemarle Corporation (NYSE: ALB) leads the world in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to pioneer new ways to move, power, connect and protect with people and planet in mind. A reliable and high-quality global supply of lithium and bromine allows us to deliver advanced solutions for our customers. Learn more about how the people of Albemarle are enabling a more resilient world at Albemarle.com, LinkedIn and X.

      Albemarle regularly posts information to Albemarle.com, including notification of events, news, financial performance, investor presentations and webcasts, non-GAAP reconciliations, U.S. Securities and Exchange Commission filings and other information regarding the company, its businesses and the markets it serves.

      Forward-Looking Statements
      This press release contains statements concerning our expectations, anticipations and beliefs regarding the future, which constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements, which are based on assumptions that we have made as of the date hereof and are subject to known and unknown risks and uncertainties, often contain words such as "anticipate," "believe," "estimate," "expect," "guidance," "intend," "may," "outlook," "scenario," "should," "would," and "will". Forward-looking statements may include statements regarding: our 2025 company and segment outlooks, including expected market pricing of lithium and spodumene and other underlying assumptions and outlook considerations; planned sale of a controlling stake in Ketjen and the amount of the proceeds for the controlling stake in Ketjen and our interest in the Eurecat JV; timing for completion of both transactions, including obtaining regulatory approvals and meeting other closing conditions; expectations regarding use of proceeds from the both transactions; expected capital expenditure amounts and the corresponding impact on cash flow; expected impact of tariffs and other trade restrictions; market pricing of lithium carbonate equivalent and spodumene; plans and expectations regarding other projects and activities, cost reductions and accounting charges, and all other information relating to matters that are not historical facts. Factors that could cause Albemarle's actual results to differ materially from the outlook expressed or implied in any forward-looking statement include: changes in economic and business conditions; changes in trade policies and tariffs; financial and operating performance of customers; timing and magnitude of customer orders; fluctuations in lithium market prices; production volume shortfalls; increased competition; changes in product demand; availability and cost of raw materials and energy; technological change and development; fluctuations in foreign currencies; changes in laws and government regulation; regulatory actions, proceedings, claims or litigation; cyber-security breaches, terrorist attacks, industrial accidents or natural disasters; geopolitical conflicts and political unrest; trade policies and tariffs; changes in inflation or interest rates; volatility in the debt and equity markets; acquisition and divestiture transactions; timing and success of projects; performance of Albemarle's partners in joint ventures and other projects; changes in credit ratings; and the other factors detailed from time to time in the reports Albemarle files with the SEC, including those described under "Risk Factors" in Albemarle's most recent Annual Report on Form 10-K and any subsequently filed Quarterly Reports on Form 10-Q, which are filed with the SEC and available on the investor section of Albemarle's website (investors.albemarle.com) and on the SEC's website at www.sec.gov. These forward-looking statements speak only as of the date of this press release. Albemarle assumes no obligation to provide any revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws.

      Albemarle Corporation and Subsidiaries

      Consolidated Statements of Loss

      (In Thousands Except Per Share Amounts) (Unaudited)



      Three Months Ended


      Nine Months Ended


      September 30,


      September 30,


      2025


      2024


      2025


      2024

      Net sales

      $ 1,307,829


      $ 1,354,692


      $ 3,714,702


      $ 4,145,813

      Cost of goods sold

      1,190,219


      1,458,726


      3,243,917


      4,221,487

      Gross profit (loss)

      117,610


      (104,034)


      470,785


      (75,674)

      Selling, general and administrative expenses

      138,577


      154,253


      394,536


      482,052

      Goodwill impairment charges

      181,070


      —


      181,070


      —

      Restructuring charges and asset write-offs

      2,275


      828,146


      5,660


      1,156,522

      Research and development expenses

      12,674


      22,397


      39,217


      66,699

      Operating loss

      (216,986)


      (1,108,830)


      (149,698)


      (1,780,947)

      Interest and financing expenses

      (50,959)


      (47,760)


      (149,875)


      (120,916)

      Other income (expenses), net

      28,799


      (22,256)


      32,490


      61,311

      Loss before income taxes and equity in net income of unconsolidated investments

      (239,146)


      (1,178,846)


      (267,083)


      (1,840,552)

      Income tax (benefit) expense

      (30,565)


      110,853


      (449)


      76,472

      Loss before equity in net income of unconsolidated investments

      (208,581)


      (1,289,699)


      (266,634)


      (1,917,024)

      Equity in net income of unconsolidated investments (net of tax)

      60,640


      229,058


      203,184


      696,436

      Net loss

      (147,941)


      (1,060,641)


      (63,450)


      (1,220,588)

      Net income attributable to noncontrolling interests

      (12,753)


      (8,351)


      (32,999)


      (34,154)

      Net loss attributable to Albemarle Corporation

      (160,694)


      (1,068,992)


      (96,449)


      (1,254,742)

      Mandatory convertible preferred stock dividends

      (41,688)


      (41,687)


      (125,063)


      (94,959)

      Net loss attributable to Albemarle Corporation common shareholders

      $  (202,382)


      $  (1,110,679)


      $  (221,512)


      $  (1,349,701)

      Basic loss per share attributable to common shareholders

      $        (1.72)


      $           (9.45)


      $        (1.88)


      $         (11.49)

      Diluted loss per share attributable to common shareholders

      $        (1.72)


      $           (9.45)


      $        (1.88)


      $         (11.49)









      Weighted-average common shares outstanding – basic

      117,685


      117,535


      117,651


      117,505

      Weighted-average common shares outstanding – diluted

      117,685


      117,535


      117,651


      117,505

      Albemarle Corporation and Subsidiaries

      Condensed Consolidated Balance Sheets

      (In Thousands) (Unaudited)



      September 30,


      December 31,


      2025


      2024

      ASSETS




      Current assets:




      Cash and cash equivalents

      $        1,931,758


      $        1,192,230

      Trade accounts receivable

      733,477


      742,201

      Other accounts receivable

      107,701


      238,384

      Inventories

      1,532,622


      1,502,531

      Other current assets

      249,347


      166,916

        Total current assets

      4,554,905


      3,842,262

      Property, plant and equipment

      12,902,998


      12,523,368

      Less accumulated depreciation and amortization

      3,680,755


      3,191,898

        Net property, plant and equipment

      9,222,243


      9,331,470

      Investments

      914,040


      1,117,739

      Other assets

      736,279


      504,711

      Goodwill

      1,490,869


      1,582,714

      Other intangibles, net of amortization

      229,949


      230,753

        Total assets

      $      17,148,285


      $      16,609,649

      LIABILITIES AND EQUITY




      Current liabilities:




      Accounts payable to third parties

      $           780,377


      $           793,455

      Accounts payable to related parties

      122,794


      150,432

      Accrued expenses

      500,940


      467,997

      Current portion of long-term debt

      445,384


      398,023

      Dividends payable

      61,339


      61,282

      Income taxes payable

      93,120


      95,275

        Total current liabilities

      2,003,954


      1,966,464

      Long-term debt

      3,181,009


      3,118,142

      Postretirement benefits

      31,915


      31,930

      Pension benefits

      118,004


      116,192

      Other noncurrent liabilities

      1,137,211


      819,204

      Deferred income taxes

      407,134


      358,029

      Commitments and contingencies




      Equity:




      Albemarle Corporation shareholders' equity:




      Common stock

      1,177


      1,176

      Mandatory convertible preferred stock

      2,235,105


      2,235,105

      Additional paid-in capital

      3,011,210


      2,985,606

      Accumulated other comprehensive loss

      (368,592)


      (742,062)

      Retained earnings

      5,117,213


      5,481,692

        Total Albemarle Corporation shareholders' equity

      9,996,113


      9,961,517

      Noncontrolling interests

      272,945


      238,171

        Total equity

      10,269,058


      10,199,688

        Total liabilities and equity

      $      17,148,285


      $      16,609,649

      Albemarle Corporation and Subsidiaries

      Selected Consolidated Cash Flow Data

      (In Thousands) (Unaudited)



      Nine Months Ended

      September 30,


      2025


      2024

      Cash and cash equivalents at beginning of year

      $   1,192,230


      $      889,900

      Cash flows from operating activities:




      Net loss

      (63,450)


      (1,220,588)

      Adjustments to reconcile net loss to cash flows from operating activities:




      Depreciation and amortization

      494,968


      425,532

      Non-cash goodwill impairment charges

      181,070


      —

      Non-cash restructuring and asset write-offs

      —


      1,075,888

      Stock-based compensation and other

      28,048


      24,443

      Equity in net income of unconsolidated investments (net of tax)

      (203,184)


      (696,436)

      Dividends received from unconsolidated investments and nonmarketable securities

      89,048


      348,358

      Pension and postretirement expense

      5,361


      3,806

      Pension and postretirement contributions

      (15,849)


      (13,339)

      Realized loss on investments in marketable securities

      —


      33,746

      Unrealized (gain) loss on investments in marketable securities

      (4,955)


      26,982

      Deferred income taxes

      10,316


      (112,777)

      Working capital changes

      46,478


      830,851

      Noncurrent liability changes and other, net

      325,931


      (34,211)

      Net cash provided by operating activities

      893,782


      692,255

      Cash flows from investing activities:




      Capital expenditures

      (434,416)


      (1,337,719)

      Proceeds from sale of property and equipment

      25,651


      —

      Proceeds from sale of available for sale debt securities

      288,000


      —

      Proceeds (payments) from settlement of foreign currency forward contracts, net

      144,540


      (1,956)

      Sales of marketable securities, net

      7,038


      83,651

      Investments in equity investments and nonmarketable securities

      (180)


      (217)

      Net cash provided by (used in) investing activities

      30,633


      (1,256,241)

      Cash flows from financing activities:




      Proceeds from issuance of mandatory convertible preferred stock

      —


      2,236,750

      Repayments of long-term debt and credit agreements

      (47,947)


      (84,403)

      Proceeds from borrowings of long-term debt and credit agreements

      38,332


      84,403

      Other debt repayments, net

      (3,694)


      (629,434)

      Dividends paid to common shareholders

      (142,899)


      (140,929)

      Dividends paid to mandatory convertible preferred shareholders

      (125,063)


      (81,059)

      Dividends paid to noncontrolling interests

      (18,169)


      (37,176)

      Proceeds from exercise of stock options

      1,494


      114

      Withholding taxes paid on stock-based compensation award distributions

      (3,170)


      (10,892)

      Other

      (55)


      (2,758)

      Net cash (used in) provided by financing activities

      (301,171)


      1,334,616

      Net effect of foreign exchange on cash and cash equivalents

      116,284


      3,989

      Increase in cash and cash equivalents

      739,528


      774,619

      Cash and cash equivalents at end of period

      $   1,931,758


      $   1,664,519

      Albemarle Corporation and Subsidiaries

      Consolidated Summary of Segment Results

      (In Thousands) (Unaudited) 



      Three Months Ended


      Nine Months Ended


      September 30,


      September 30,


      2025


      2024


      2025


      2024

      Net sales:








      Energy Storage

      $   708,755


      $   767,291


      $ 1,950,976


      $ 2,398,299

      Specialties

      344,960


      342,376


      1,017,534


      993,041

      Ketjen

      254,114


      245,025


      746,192


      754,473

      Total net sales

      $ 1,307,829


      $ 1,354,692


      $ 3,714,702


      $ 4,145,813









      Adjusted EBITDA:








      Energy Storage

      $   124,077


      $   142,887


      $   530,157


      $   623,862

      Specialties

      75,544


      56,273


      207,187


      155,629

      Ketjen

      33,566


      35,473


      100,721


      95,288

      Total segment adjusted EBITDA

      233,187


      234,633


      838,065


      874,779

      Corporate

      (7,557)


      (23,135)


      (8,816)


      14,315

      Total adjusted EBITDA

      $   225,630


      $   211,498


      $   829,249


      $   889,094

      See accompanying non-GAAP reconciliations below.

      Additional Information Regarding Non-GAAP Measures

      It should be noted that adjusted net income (loss) attributable to Albemarle Corporation, adjusted net loss attributable to Albemarle Corporation common shareholders, adjusted diluted loss per share attributable to common shareholders, non-operating pension and other post-employment benefit ("OPEB") items per diluted share, non-recurring and other unusual items per diluted share, adjusted effective income tax rates, EBITDA, adjusted EBITDA (on a consolidated basis), EBITDA margin and adjusted EBITDA margin, operating cash flow conversion, and free cash flow are financial measures that are not required by, or presented in accordance with, accounting principles generally accepted in the United States, or GAAP. These non-GAAP measures should not be considered as alternatives to Net loss attributable to Albemarle Corporation ("earnings") or other comparable measures calculated and reported in accordance with GAAP. These measures are presented here to provide additional useful measurements to review the company's operations, provide transparency to investors and enable period-to-period comparability of financial performance. The company's chief operating decision maker uses these measures to assess the ongoing performance of the company and its segments, as well as for business and enterprise planning purposes.

      A description of other non-GAAP financial measures that Albemarle uses to evaluate its operations and financial performance, and reconciliation of these non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP can be found on the following pages of this press release, which is also is available on Albemarle's website at https://investors.albemarle.com. The company does not provide a reconciliation of forward-looking non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP, as the company is unable to estimate significant non-recurring or unusual items without unreasonable effort. The amounts and timing of these items are uncertain and could be material to the company's results calculated in accordance with GAAP.

      ALBEMARLE CORPORATION AND SUBSIDIARIES
      Non-GAAP Reconciliations
      (Unaudited)

      See below for a reconciliation of adjusted net income (loss) attributable to Albemarle Corporation, adjusted net loss attributable to Albemarle Corporation common shareholders, EBITDA and adjusted EBITDA (on a consolidated basis), which are non-GAAP financial measures, to Net loss attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with GAAP. Adjusted net income (loss) attributable to Albemarle Corporation is defined as net loss attributable to Albemarle Corporation before the non-recurring, other unusual and non-operating pension and other post-employment benefit (OPEB) items as listed below. The non-recurring and unusual items may include acquisition and integration related costs, gains or losses on sales of businesses, restructuring charges, facility divestiture charges, certain litigation and arbitration costs and charges, and other significant non-recurring items. Adjusted net loss attributable to Albemarle Corporation common stockholders is defined as adjusted net income (loss) attributable to Albemarle Corporation after mandatory convertible preferred stock dividends. EBITDA is defined as net loss attributable to Albemarle Corporation before interest and financing expenses, income tax expense, and depreciation and amortization. Adjusted EBITDA is defined as EBITDA plus or minus the proportionate share of Windfield Holdings income tax expense, non-recurring, other unusual and non-operating pension and OPEB items as listed below.


      Three Months Ended


      Nine Months Ended


      September 30,


      September 30,


      2025


      2024


      2025


      2024

      In thousands, except percentages and per share amounts

      $


      % of net sales


      $


      % of net sales


      $


      % of net sales


      $


      % of net sales

      Net loss attributable to Albemarle Corporation

      ($160,694)




      $  (1,068,992)




      ($96,449)




      $  (1,254,742)



      Add back:
















      Non-operating pension and OPEB items (net of tax)

      189




      (344)




      483




      (1,031)



      Non-recurring and other unusual items (net of tax)

      180,025




      928,771




      190,533




      1,203,313



      Adjusted net income (loss) attributable to Albemarle Corporation

      19,520




      (140,565)




      94,567




      (52,460)



          Mandatory convertible preferred stock dividends

      (41,688)




      (41,687)




      (125,063)




      (94,959)



      Adjusted net loss attributable to Albemarle Corporation common shareholders

      ($22,168)




      $     (182,252)




      $      (30,496)




      $    (147,419)



















      Adjusted diluted loss per share attributable to common shareholders

      $           (0.19)




      $           (1.55)




      $          (0.26)




      $          (1.25)



















      Adjusted weighted-average common shares outstanding – diluted

      117,685




      117,535




      117,651




      117,505



















      Net loss attributable to Albemarle Corporation

      ($160,694)


      (12.3) %


      $   (1,068,992)


      (78.9) %


      ($96,449)


      (2.6) %


      $  (1,254,742)


      (30.3) %

      Add back:
















      Interest and financing expenses

      50,959


      3.9 %


      47,760


      3.5 %


      149,875


      4.0 %


      120,916


      2.9 %

      Income tax (benefit) expense

      (30,565)


      (2.3) %


      110,853


      8.2 %


      (449)


      — %


      76,472


      1.8 %

      Depreciation and amortization

      164,483


      12.6 %


      163,502


      12.1 %


      494,968


      13.3 %


      425,532


      10.3 %

      EBITDA

      24,183


      1.8 %


      (746,877)


      (55.1) %


      547,945


      14.8 %


      (631,822)


      (15.2) %

      Proportionate share of Windfield income tax expense

      20,023


      1.5 %


      99,523


      7.3 %


      78,499


      2.1 %


      292,992


      7.1 %

      Non-operating pension and OPEB items

      367


      — %


      (331)


      — %


      978


      — %


      (993)


      — %

      Non-recurring and other unusual items

      181,057


      13.8 %


      859,183


      63.4 %


      201,827


      5.4 %


      1,228,917


      29.6 %

      Adjusted EBITDA

      $225,630


      17.3 %


      $ 211,498


      15.6 %


      $     829,249


      22.3 %


      $ 889,094


      21.4 %

















      Net sales

      $    1,307,829




      $     1,354,692




      $  3,714,702




      $    4,145,813



      Non-operating pension and OPEB items, consisting of mark-to-market actuarial gains/losses, settlements/curtailments, interest cost and expected return on assets, are not allocated to Albemarle's operating segments and are included in the Corporate category. In addition, the company believes that these components of pension cost are mainly driven by market performance, and the company manages these separately from the operational performance of the company's businesses. In accordance with GAAP, these non-operating pension and OPEB items are included in Other income (expenses), net. Non-operating pension and OPEB items were as follows (in thousands):


      Three Months Ended


      Nine Months Ended


      September 30,


      September 30,


      2025


      2024


      2025


      2024

      Interest cost

      $       8,976


      $       8,523


      $     26,710


      $     25,529

      Expected return on assets

      (8,609)


      (8,854)


      (25,732)


      (26,522)

      Total

      $          367


      $        (331)


      $          978


      $        (993)

      In addition to the non-operating pension and OPEB items disclosed above, the company has identified certain other items and excluded them from Albemarle's adjusted net (loss) income calculation for the periods presented. A listing of these items, as well as a detailed description of each follows below (per diluted share):


      Three Months Ended


      Nine Months Ended


      September 30,


      September 30,


      2025


      2024


      2025


      2024

      Restructuring charges and asset write-offs(1)

      $         0.02


      $         7.91


      $         0.03


      $         9.99

      Goodwill impairment charges(2)

      1.49


      —


      1.49


      —

      Acquisition and integration related costs(3)

      0.01


      —


      0.03


      0.03

      (Gain) loss in fair value of public equity securities(4)

      (0.05)


      0.03


      (0.02)


      0.50

      Other(5)

      0.03


      (0.04)


      0.07


      (0.23)

      Tax related items(6)

      0.03


      —


      0.02


      (0.05)

      Total non-recurring and other unusual items

      $         1.53


      $         7.90


      $         1.62


      $       10.24

      (1)

      The Company took several actions during 2024 as part of a broader effort that are focused on preserving its world-class resource advantages, optimizing its global conversion network, improving the Company's cost competitiveness and efficiency, reducing capital intensity and enhancing the Company's financial flexibility. Those actions included stopping construction of Kemerton Trains 3 and 4, as well as certain other capital projects, placing Kemerton Train 2 in care and maintenance and transitioning the Company's operating structure to a fully integrated functional model (excluding Ketjen). Additionally, as part of this restructuring plan, we placed the Chengdu, China conversion plant into care and maintenance during the first half of 2025. As a result, the Company recorded restructuring and asset write-off charges of $2.3 million and $5.7 million in Restructuring charges and asset write-offs for the three and nine months ended September 30, 2025, respectively, and a loss of $0.1 million in Other income (expenses), net for the nine months ended September 30, 2025. Due to the impact of valuation allowances, this resulted in total after-tax gains of $2.2 million and $3.0 million, or $0.02 and $0.03 per share for the three and nine months ended September 30, 2025, respectively. During the three and nine months ended September 30, 2024, the Company recorded restructuring and asset write-off charges of $16.5 million in Cost of goods sold, $828.1 million and $1.2 billion in Restructuring charges and asset write-offs, respectively, and losses of $16.2 million and $21.5 million in Other income (expenses), net, respectively. In total, this resulted in after-tax losses of $930.0 million and $1.2 billion, or $7.91 and $9.99 per share for the three and nine months ended September 30, 2024, respectively. The tax impact includes a valuation allowance to reverse the tax benefits associated with the expenses recorded in Australia.




      (2)

      Non-cash goodwill impairment charge of $181.1 million ($175.7 million or $1.49 per share after income tax expense) recorded during the three and nine months ended September 30, 2025 related to our Refining Solutions reporting unit within our Ketjen reportable segment.




      (3)

      Costs related to the acquisition, integration and divestitures for various significant projects, recorded in Selling, general and administrative expenses for the three and nine months ended September 30, 2025 were $1.9 million and $5.1 million ($1.5 million and $4.0 million after income taxes, or $0.01 and $0.03 per share), respectively, and for the three and nine months ended September 30, 2024 were $0.4 million and $3.9 million ($0.4 million and $3.1 million after income taxes, or less than $0.01 and $0.03 per share), respectively.




      (4)

      Gains of $8.0 million and $3.1 million ($6.2 million and $2.5 million after income taxes, or $0.05 and $0.02 per share) recorded in Other income (expenses), net resulting from the net change in fair value of investments in public equity securities for the three and nine months ended September 30, 2025, respectively. Losses of $5.0 million and $32.2 million recorded in Other income (expenses), net resulting from the net change in fair value of investments in public equity securities for the three and nine months ended September 30, 2024, respectively, and a loss of $33.7 million recorded in Other income (expenses), net for the nine months ended September 30, 2024 resulting from the sale of investments in public equity securities ($3.9 million and $58.9 million after income taxes, or $0.03 and $0.50 per share).




      (5)

      Other adjustments for the three months ended September 30, 2025 included amounts recorded in:


      •

      Selling, general and administrative expenses - $2.0 million of severance expenses not related to a restructuring plan, $1.4 million of expenses related to the redemption of preferred equity in a Grace subsidiary, $1.4 million related to the write-off of certain fixed assets and $1.3 million of expenses related to certain historical legal matters, partially offset by $1.9 million of gains from the sale of assets not part of our production operations.


      •

      Other income (expenses), net - $0.5 million gain resulting from the adjustment of indemnification related to a previously disposed business.


      After income taxes, these net losses totaled $3.0 million, or $0.03 per share.





      Other adjustments for the three months ended September 30, 2024 included amounts recorded in:


      •

      Selling, general and administrative expenses - $0.1 million of expenses related to certain historical legal matters.


      •

      Other income (expenses), net - $9.2 million gain from PIK dividends of preferred equity in a Grace subsidiary, partially offset by $2.0 million of a loss resulting from the adjustment of indemnification related to a previously disposed business.


      After income taxes, these net gains totaled $5.2 million, or $0.04 per share.





      Other adjustments for the nine months ended September 30, 2025 included amounts recorded in:


      •

      Selling, general and administrative expenses - $13.3 million of gains from the sale of assets not part of our production operations, partially offset by $3.8 million of severance expenses not related to a restructuring plan, $1.9 million of expenses related to certain historical legal matters, $1.4 million of expenses related to the redemption of preferred equity in a Grace subsidiary and $1.4 million related to the write-off of certain fixed assets.


      •

      Other income (expenses), net - $38.0 million loss resulting from the redemption of preferred equity in a Grace subsidiary and $1.9 million of charges for asset retirement obligations at a site not part of our operations, partially offset by $19.8 million of income from PIK dividends of the preferred equity in a Grace subsidiary prior to redemption and a $2.4 million gain primarily resulting from the adjustment of indemnification related to previously disposed businesses.


      After income taxes, these net losses totaled $8.4 million, or $0.07 per share.





      Other adjustments for the nine months ended September 30, 2024 included amounts recorded in:


      •

      Cost of goods sold - $1.4 million of expenses related to non-routine labor and compensation related costs that are outside normal compensation arrangements.


      •

      Selling, general and administrative expenses - $5.3 million of expenses related to certain historical legal and environmental matters.


      •

      Other income (expenses), net - $26.8 million gain from PIK dividends of preferred equity in a Grace subsidiary, a $17.3 million gain primarily from the sale of assets at a site not part of our operations, a $0.6 million gain from an updated cost estimate of an environmental reserve at a site not part of our operations and a $0.4 million net gain primarily resulting from the adjustment of indemnification related to previously disposed businesses, partially offset by $2.9 million of charges for asset retirement obligations at a site not part of our operations.


      After income taxes, these net gains totaled $26.2 million, or $0.23 per share.




      (6)

      Included in Income tax (benefit) expense for the three and nine months ended September 30, 2025 are discrete net tax expenses of $3.9 million, or $0.03 per share, and $1.9 million, or $0.02 per share, respectively, primarily related to the impact of foreign tax reserves, the change in the Company's assertion over book and tax basis differences of a foreign entity and changes in certain foreign tax rates.





      Included in Income tax (benefit) expense for the three and nine months ended September 30, 2024 are discrete net tax benefits of $0.4 million, or less than $0.01 per share, and $6.1 million, or $0.05 per share, respectively, primarily related to the reduction in a foreign tax reserve and excess tax benefits realized from stock-based compensation arrangements.

      See below for a reconciliation of the adjusted effective income tax rate, the non-GAAP financial measure, to the effective income tax rate, the most directly comparable financial measure calculated and reporting in accordance with GAAP (in thousands, except percentages).


      Loss before income taxes and equity in net income of unconsolidated investments


      Income tax (benefit) expense


      Effective income tax rate

      Three months ended September 30, 2025






      As reported

      $                   (239,146)


      $                     (30,565)


      12.8 %

      Non-recurring, other unusual and non-operating pension and OPEB
      items

      181,424


      1,210



      As adjusted

      $                     (57,722)


      $                     (29,355)


      50.9 %







      Three months ended September 30, 2024






      As reported

      $                (1,178,846)


      $                    110,853


      (9.4) %

      Non-recurring, other unusual and non-operating pension and OPEB items

      858,852


      (69,575)



      As adjusted

      $                   (319,994)


      $                      41,278


      (12.9) %







      Nine months ended September 30, 2025






      As reported

      $                   (267,083)


      $                         (449)


      0.2 %

      Non-recurring, other unusual and non-operating pension and OPEB items

      202,805


      11,789



      As adjusted

      $                     (64,278)


      $                      11,340


      (17.6) %







      Nine months ended September 30, 2024






      As reported

      $                (1,840,552)


      $                      76,472


      (4.2) %

      Non-recurring, other unusual and non-operating pension and OPEB items

      1,227,924


      25,642



      As adjusted

      $                   (612,628)


      $                    102,114


      (16.7) %

      Albemarle Investor Relations Contact: +1 (980) 308-6194, [email protected]

      SOURCE Albemarle Corporation

      Modal title

      Also from this source

      Albemarle Reports Third Quarter 2026 Results

      Albemarle Reports Third Quarter 2026 Results

      Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its ...

      Albemarle Announces Quarterly Common Stock Dividend

      Albemarle Announces Quarterly Common Stock Dividend

      The Board of Directors of Albemarle Corporation (NYSE: ALB) today announced that it declared a quarterly common stock dividend of $0.41 per share....

      More Releases From This Source

      Explore

      Chemical

      Chemical

      Mining & Metals

      Mining & Metals

      Mining

      Mining

      Utilities

      Utilities

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.